{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T05:28:04Z","timestamp":1793597284928,"version":"4.5.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273990"],"award-info":[{"award-number":["82273990"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2023YFA1801100"],"award-info":[{"award-number":["2023YFA1801100"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004374","name":"Chongqing Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011360","name":"State Key Laboratory of Natural Medicines","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011360","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhep.2025.01.008","type":"journal-article","created":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T19:48:16Z","timestamp":1737575296000},"page":"383-396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis"],"prefix":"10.1016","volume":"83","author":[{"given":"Sitong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenming","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4379-8748","authenticated-orcid":false,"given":"Xiaojun","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2025.01.008_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.01.008_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.008_bib3","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/HEP.0000000000000679","article-title":"A public health perspective on mitigating the global burden of chronic liver disease","volume":"79","author":"Balakrishnan","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.008_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/d41573-024-00051-1","article-title":"NASH field celebrates 'hurrah moment' with a first FDA drug approval for the liver disease","volume":"23","author":"Kingwell","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.jhep.2025.01.008_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/TP.0000000000002480","article-title":"Nonalcoholic fatty liver disease: basic pathogenetic mechanisms in the progression from NAFLD to NASH","volume":"103","author":"Pierantonelli","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.jhep.2025.01.008_bib6","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jhep.2011.05.019","article-title":"Lipotoxicity in NASH","volume":"56","author":"Fuchs","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.008_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","article-title":"Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it","volume":"6","author":"Begriche","year":"2006","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jhep.2025.01.008_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jnutbio.2021.108888","article-title":"Nobiletin mitigates hepatocytes death, liver inflammation, and fibrosis in a murine model of NASH through modulating hepatic oxidative stress and mitochondrial dysfunction","volume":"100","author":"Li","year":"2022","journal-title":"J Nutr Biochem"},{"key":"10.1016\/j.jhep.2025.01.008_bib9","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.jhep.2025.01.008_bib10","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.008_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102691","article-title":"STING mediates hepatocyte pyroptosis in liver fibrosis by Epigenetically activating the NLRP3 inflammasome","volume":"62","author":"Xiao","year":"2023","journal-title":"Redox Biol"},{"key":"10.1016\/j.jhep.2025.01.008_bib12","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrgastro.2015.94","article-title":"Inflammasome activation and function in liver disease","volume":"12","author":"Szabo","year":"2015","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2025.01.008_bib13","series-title":"NLRP3 inflammasome activation is required for fibrosis development in NAFLD","author":"Wree","year":"2014"},{"key":"10.1016\/j.jhep.2025.01.008_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.01.008_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hep.24341","article-title":"Fatty acid and endotoxin activate inflammasomes in mouse hepatocytes that release danger signals to stimulate immune cells","volume":"54","author":"Csak","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.008_bib16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jhep.2025.01.008_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/nature10759","article-title":"Inflammasomes in health and disease","volume":"481","author":"Strowig","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.01.008_bib18","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","article-title":"The gasdermins, a protein family executing cell death and inflammation","volume":"20","author":"Broz","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jhep.2025.01.008_bib19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","article-title":"Gasdermin-mediated programmed necrotic cell death","volume":"42","author":"Shi","year":"2017","journal-title":"Trends Biochemical Sciences"},{"key":"10.1016\/j.jhep.2025.01.008_bib20","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nature15514","article-title":"Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death","volume":"526","author":"Shi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.01.008_bib21","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature13683","article-title":"Inflammatory caspases are innate immune receptors for intracellular LPS","volume":"514","author":"Shi","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.01.008_bib22","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jhep.2020.07.041","article-title":"Hepatocyte pyroptosis and release of inflammasome particles induce stellate cell activation and liver fibrosis","volume":"74","author":"Gaul","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2025.01.008_bib23","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1074\/jbc.M707997200","article-title":"Human UMP-CMP kinase 2, a novel nucleoside monophosphate kinase localized in mitochondria","volume":"283","author":"Xu","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jhep.2025.01.008_bib24","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/s41586-018-0372-z","article-title":"New mitochondrial DNA synthesis enables NLRP3 inflammasome activation","volume":"560","author":"Zhong","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.01.008_bib25","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/j.immuni.2022.06.007","article-title":"Oxidized DNA fragments exit mitochondria via mPTP- and VDAC-dependent channels to activate NLRP3 inflammasome and interferon signaling","volume":"55","author":"Xian","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2025.01.008_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","article-title":"Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis","volume":"36","author":"Shimada","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2025.01.008_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1449","article-title":"Dracorhodin targeting CMPK2 attenuates inflammation: a novel approach to sepsis therapy","volume":"13","author":"Zhang","year":"2023","journal-title":"Clin translational Med"},{"key":"10.1016\/j.jhep.2025.01.008_bib28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/j.immuni.2021.05.004","article-title":"Metformin inhibition of mitochondrial ATP and DNA synthesis abrogates NLRP3 inflammasome activation and pulmonary inflammation","volume":"54","author":"Xian","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jhep.2025.01.008_bib29","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.3892\/etm.2021.10793","article-title":"CMPK2 accelerates liver ischemia\/reperfusion injury via the NLRP3 signaling pathway","volume":"22","author":"Luo","year":"2021","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.jhep.2025.01.008_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110878","article-title":"ASIC1a-CMPK2-mediated M1 macrophage polarization exacerbates chondrocyte senescence in osteoarthritis through IL-18","volume":"124","author":"Dong","year":"2023","journal-title":"Int immunopharmacology"},{"key":"10.1016\/j.jhep.2025.01.008_bib31","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13075-021-02470-6","article-title":"Mitochondrial protein CMPK2 regulates IFN alpha-enhanced foam cell formation, potentially contributing to premature atherosclerosis in SLE","volume":"23","author":"Lai","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jhep.2025.01.008_bib32","article-title":"Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke","volume":"5","author":"Guan","year":"2024","journal-title":"Cel Rep Med"},{"key":"10.1016\/j.jhep.2025.01.008_bib33","doi-asserted-by":"crossref","first-page":"E7245","DOI":"10.1073\/pnas.1704155114","article-title":"Kinetic and high-throughput profiling of epigenetic interactions by 3D-carbene chip-based surface plasmon resonance imaging technology","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2025.01.008_bib34","doi-asserted-by":"crossref","first-page":"12260","DOI":"10.1128\/JVI.01304-07","article-title":"Structure of adeno-associated virus serotype 8, a gene therapy vector","volume":"81","author":"Nam","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.jhep.2025.01.008_bib35","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI83885","article-title":"Hepatocyte mitochondrial DNA drives nonalcoholic steatohepatitis by activation of TLR9","volume":"126","author":"Garcia-Martinez","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.01.008_bib36","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.26592","article-title":"NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice","volume":"59","author":"Wree","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.008_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172715","article-title":"Liraglutide ameliorates non-alcoholic steatohepatitis by inhibiting NLRP3 inflammasome and pyroptosis activation via mitophagy","volume":"864","author":"Yu","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jhep.2025.01.008_bib38","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fphar.2020.00151","article-title":"Nordihydroguaiaretic acid: from herbal medicine to clinical development for cancer and chronic diseases","volume":"11","author":"Manda","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jhep.2025.01.008_bib39","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/290457a0","article-title":"Sequence and organization of the human mitochondrial genome","volume":"290","author":"Anderson","year":"1981","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2025.01.008_bib40","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/hep.32731","article-title":"Mitochondrial stress in advanced fibrosis and cirrhosis associated with chronic hepatitis B, chronic hepatitis C, or nonalcoholic steatohepatitis","volume":"77","author":"Loureiro","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2025.01.008_bib41","doi-asserted-by":"crossref","first-page":"100555","DOI":"10.1016\/j.jhepr.2022.100555","article-title":"XBP1-mediated activation of the STING signalling pathway in macrophages contributes to liver fibrosis progression","volume":"4","author":"Wang","year":"2022","journal-title":"JHEP Rep\u202f: innovation Hepatol"},{"key":"10.1016\/j.jhep.2025.01.008_bib42","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1172\/JCI121842","article-title":"STING-mediated inflammation in Kupffer cells contributes to progression of nonalcoholic steatohepatitis","volume":"129","author":"Yu","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2025.01.008_bib43","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1097\/PAI.0b013e31803156d5","article-title":"Cytoplasmic fine granular expression of 8-hydroxydeoxyguanosine reflects early mitochondrial oxidative DNA damage in nonalcoholic fatty liver disease","volume":"16","author":"Nomoto","year":"2008","journal-title":"Appl Immunohistochem Mol Morphol : AIMM"},{"key":"10.1016\/j.jhep.2025.01.008_bib44","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.cmet.2015.04.004","article-title":"Adaptation of hepatic mitochondrial function in humans with non-alcoholic fatty liver is lost in steatohepatitis","volume":"21","author":"Koliaki","year":"2015","journal-title":"Cel Metab"},{"key":"10.1016\/j.jhep.2025.01.008_bib46","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1016\/j.bmcl.2007.04.092","article-title":"Inhibition of IGF-1R and lipoxygenase by nordihydroguaiaretic acid (NDGA) analogs","volume":"17","author":"Blecha","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.jhep.2025.01.008_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110538","article-title":"Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH)","volume":"498","author":"Han","year":"2019","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.jhep.2025.01.008_bib48","article-title":"Effect of creosote bush-derived NDGA on expression of genes involved in lipid metabolism in liver of high-fructose fed rats: relevance to NDGA amelioration of hypertriglyceridemia and hepatic steatosis","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS one"},{"key":"10.1016\/j.jhep.2025.01.008_bib49","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/load014","article-title":"Weight loss increases skeletal muscle mitochondrial energy efficiency in obese mice","volume":"2","author":"Ferrara","year":"2023","journal-title":"Life Metab"},{"key":"10.1016\/j.jhep.2025.01.008_bib50","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2017.01.022","article-title":"NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice","volume":"66","author":"Mridha","year":"2017","journal-title":"J Hepatol"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2026.05.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000}},{"DOI":"10.1016\/j.jhep.2026.05.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827825000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T21:12:24Z","timestamp":1773349944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827825000145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S0168827825000145"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2025.01.008","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular CMPK2 promotes the development of metabolic dysfunction-associated steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2025.01.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}